Phase I Trial of BAY1251152 for Advanced Blood Cancers

Clinical trial NCT02745743 · COMPLETED

Trial details

NCT number: NCT02745743
Sponsor: Bayer
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Hematologic Neoplasms

Start date: 2016-06-17
Primary completion: 2018-08-03
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.